Target intelligence / Profile preview

CD4+ T-cell receptor specific for Dermatophagoides pteronyssinus allergen 2–MHC class II complex (Der p 2-specific TCR)

Target
Der p 2-specific TCR
Molecular classification
Receptor, T-cell receptor
01

Overview

The CD4+ T-cell receptor (TCR) specific for Der p 2–MHC class II complexes is a pivotal mediator in the development and persistence of house dust mite (HDM) allergy. Der p 2 is a major 14-kDa allergen from Dermatophagoides pteronyssinus that possesses structural homology to MD-2, allowing it to facilitate TLR4 signaling and promote potent Th2-biased immune responses (PMID: 19633648). When Der p 2 is internalized and processed by antigen-presenting cells, its peptide fragments are displayed on MHC class II molecules for recognition by these specific TCRs. This interaction leads to the activation of CD4+ T cells, which in allergic individuals secrete cytokines such as IL-4, IL-5, and IL-13, driving IgE production and chronic eosinophilic inflammation in the airways (PMID: 30103050). Therapeutic strategies targeting this TCR-MHC interaction, such as allergen-specific immunotherapy (AIT), aim to induce immunological tolerance by promoting the expansion of regulatory T cells (Tregs) and shifting the cytokine profile away from Th2 dominance (PMID: 28213450). The use of MHC II tetramers to track these specific T-cell populations has become a vital tool for monitoring the efficacy of desensitization treatments and understanding the mechanisms of immune deviation.

Other names
Der p 2-specific T-cell receptorHouse dust mite allergen 2-specific TCRMHC class II-restricted Der p 2-reactive TCRCD4+ T-cell receptors specific for Der p 2–MHC class II complexes
02

Mechanism of action

Induction of immune tolerance through allergen-specific immunotherapy (AIT), leading to T-cell anergy, deletion, or immune deviation from a Th2-dominated profile to a Th1 or regulatory T-cell (Treg) profile (PMID: 28213450).

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine production
04

Disease associations

Allergic asthmaAllergic rhinitisAtopic dermatitisHouse dust mite allergy
05

Safety considerations

AnaphylaxisSystemic allergic reactionsAsthma exacerbationLocal injection site reactions
06

Interacting drugs

House dust mite allergen extract

3 more in the full profile.

07

Biomarkers

Der p 2-specific IgEDer p 2-specific IgG4MHC class II tetramer bindingIL-10IL-4

Beyond the preview

Go deeper on CD4+ T-cell receptor specific for Dermatophagoides pteronyssinus allergen 2–MHC class II complex (Der p 2-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4+ T-cell receptor specific for Dermatophagoides pteronyssinus allergen 2–MHC class II complex (Der p 2-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call